RxDoctor Payments Data

Katie Bries

Nurse Practitioner · Waterloo, IANPI 1427490226

Payments from drug & device makers

$1,409in general payments, 2019–2025

Across 109 payments — averaging $12.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$657
  • Lilly USA, LLC$110
  • Axsome Therapeutics, Inc.$93
  • Novo Nordisk$82
  • Bayer$80
  • Novartis$44
  • plus $343 from 14 others

What the payments were for

  • Food & beverage$1,409100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,409 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$62,976
Medicare patients
189
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$84,511
XareltoRivaroxaban47$58,716
MounjaroTirzepatide40$57,889
EliquisApixaban69$57,312
OzempicSemaglutide25$35,878
LinzessLinaclotide19$16,304
JanuviaSitagliptin Phosphate22$14,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$12,166
TrulicityDulaglutide12$11,712
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$5,764
Potassium Chloride94$4,988
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$4,692
Pantoprazole Sodium147$3,406
Duloxetine Hcl129$2,927
Rosuvastatin Calcium132$2,907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$110$69,60152 claims
Johnson & JohnsonXarelto$24$58,71647 claims
PfizerEliquis$39$57,31269 claims
Novo NordiskOzempic$82$35,87825 claims
AbbVieLinzess$657$16,30419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in Waterloo

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →